Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the ...

The drug enhances outcomes in a high-risk patient population with a significant unmet need. Tirzepatide significantly ...

TWO blockbuster weight loss jabs have been tested against each other for the first time in a head-to-head trial. There was a ...

While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...

Modern Family’ alum Eric Stonestreet opened up to PEOPLE about living with type 2 diabetes and being unable to get a grasp on ...

Glucagon-like peptide-1 receptor agonists improve cardiovascular outcomes and reduce mortality in patients with type 2 ...

New data documented dramatic shifts in prescribing for both type 2 diabetes (T2D) and weight loss, particularly with the uptake of tirzepatide ... including heart failure, where implementation ...

The battle between weight-loss drugs continues. While studies show semaglutide (sold under the brand names Ozempic and Wegovy ...

The winner of the first major head-to-head study of weight loss jabs has been revealed.

The study, which was funded by the National Institute of Diabetes and Digestive and Kidney ... with tirzepatide being the most commonly started (31%). Use of other weight loss medications, such ...